UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan

International journal of hematology, 2021-12, Vol.114 (6), p.709-718

2021

Volltextzugriff (PDF)

Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan

International journal of hematology, 2021-12, Vol.114 (6), p.719-724

2021

Volltextzugriff (PDF)

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

Internal Medicine, 2022/07/15, Vol.61(14), pp.2215-2219

2022

Volltextzugriff (PDF)

Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case

Internal Medicine, 2018/10/15, Vol.57(20), pp.3001-3005

2018

Volltextzugriff (PDF)

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

Internal Medicine, 2022/06/01, Vol.61(11), pp.1681-1686

2022

Volltextzugriff (PDF)

Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia

International journal of hematology, 2020-05, Vol.111 (5), p.719-723

2020

Volltextzugriff (PDF)

Complete Resolution of TAFRO Syndrome (Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis and Organomegaly) after Immunosuppressive Therapies using Corticosteroids and Cyclosporin A : A Case Report

Journal of Clinical and Experimental Hematopathology, 2013, Vol.53(1), pp.95-99

2013

Volltextzugriff (PDF)

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies

Internal Medicine, 2024, pp.2900-23

2024

Volltextzugriff (PDF)

Hypercalcemia and osteolytic bone lesions as the major symptoms in a chronic lymphocytic leukemia/small lymphocytic lymphoma patient: a rare case

Journal of Clinical and Experimental Hematopathology, 2018, Vol.58(4), pp.171-174

2018

Volltextzugriff (PDF)

Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma

Annals of hematology, 2021-11, Vol.100 (11), p.2745-2754

2021

Volltextzugriff (PDF)

A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow

Internal Medicine, 2017/12/15, Vol.56(24), pp.3341-3346

2017

Volltextzugriff (PDF)

Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia

International journal of hematology, 2013-08, Vol.98 (2), p.243-246

2013

Volltextzugriff (PDF)

Lymphocyte-depleted Hodgkin Lymphoma Complicating Hemophagocytic Lymphohistiocytosis as an Initial Manifestation: A Case Report and Review of the Literature

Internal Medicine, 2012, Vol.51(21), pp.3067-3072

2012

Volltextzugriff (PDF)

An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection

International journal of hematology, 2010-09, Vol.92 (2), p.381-385

2010

Volltextzugriff (PDF)

Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura

Case reports in hematology, 2016-01, Vol.2016, p.4342820-6

2016

Volltextzugriff (PDF)

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

FEBS letters, 2007-04, Vol.581 (8), p.1631-1634

2007

Volltextzugriff (PDF)

Simple desensitization protocol for multiple myeloma patients with lenalidomide‐induced skin rash: Case series

Journal of clinical pharmacy and therapeutics, 2021-12, Vol.46 (6), p.1792-1795

2021

Volltextzugriff (PDF)

Autoimmune Hemolytic Anemia Induced by COVID-19 Vaccination

Kansenshōgaku zasshi, 2024-03, Vol.98 (2), p.146-150, Article e23007

2024

Volltextzugriff (PDF)

Autoimmune Hemolytic Anemia Induced by COVID-19 Vaccination

Kansenshogaku Zasshi, 2024/03/20, Vol.98(2), pp.146-150

2024

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient

Rinshō ketsueki, 2024, Vol.65 (2), p.74

2024

Volltextzugriff (PDF)

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash

Journal of clinical pharmacy and therapeutics, 2022-04, Vol.47 (4), p.477-482

2022

Volltextzugriff (PDF)

The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50

Leukemia research, 2017-02, Vol.53, p.35-38

2017

Volltextzugriff (PDF)

Practical management of the patients with hematological diseases during the COVID-19 pandemic in Japan

Rinshō ketsueki, 2021, Vol.62 (2), p.115

2021

Volltextzugriff (PDF)

Severe thrombocytopenia after COVID-19 mRNA vaccination

Rinshō ketsueki, 2021, Vol.62 (12), p.1684

2021

Volltextzugriff (PDF)

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma

Leukemia & lymphoma, 2021-05, Vol.62 (6), p.1405-1410

2021

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(80)
Japanisch
(51)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Humans
(44)
Life Sciences & Biomedicine
(33)
Male
(22)
Aged
(16)
Hematology
(15)
Technology
(14)
Female
(13)
Covid-19
(12)
Oncology
(12)
Physical Sciences
(12)
Middle Aged
(11)
Case Report
(10)
Multiple Myeloma
(10)
Sars-Cov-2
(10)
Animals
(9)
Chemistry
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Biological And Medical Sciences
(7)
Field Programmable Gate Arrays
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan

Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia

Complete Resolution of TAFRO Syndrome (Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis and Organomegaly) after Immunosuppressive Therapies using Corticosteroids and Cyclosporin A : A Case Report

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies

Hypercalcemia and osteolytic bone lesions as the major symptoms in a chronic lymphocytic leukemia/small lymphocytic lymphoma patient: a rare case

Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma

A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow

Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia

Lymphocyte-depleted Hodgkin Lymphoma Complicating Hemophagocytic Lymphohistiocytosis as an Initial Manifestation: A Case Report and Review of the Literature

An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection

Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

Simple desensitization protocol for multiple myeloma patients with lenalidomide‐induced skin rash: Case series

Autoimmune Hemolytic Anemia Induced by COVID-19 Vaccination

Autoimmune Hemolytic Anemia Induced by COVID-19 Vaccination

Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash

The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50

Practical management of the patients with hematological diseases during the COVID-19 pandemic in Japan

Severe thrombocytopenia after COVID-19 mRNA vaccination

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma

Suchergebnisse filtern